A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...
In Rwanda, cancer remains a leading health challenge, with breast, cervical, and prostate cancers being among the most prevalent. According to Dr. Theoneste Maniragaba, the Director of the Cancer ...
When prostate cancer metastasizes, spreads outside of the prostate itself, it typically affects the structures in its immediate vicinity. Structures near the prostate likely to be involved include ...
First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of ...
Northwell Staten Island University Hospital has announced the addition of the Focal One High-Intensity Focused Ultrasound ...
Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including milk thistle, turmeric, and green tea, that target the tumor ...
Pembrolizumab and stereotactic radiotherapy combined in subjects with advanced HCC: A phase II study (PEMRAD). This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium.
Development of a methylation-based, tissue-agnostic test for the detection of molecular residual disease by circulating tumor DNA. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...
AA = androgen ablation; D90 = percent of the prescribed dose that ≥90% of the prostate received; EBRT = external beam radiotherapy; PSA = prostate-specific antigen; V100 = percent volume ...